Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ´ç´¢º´ > Opportunities Assessment for Diabetes Therapeutics - Australia
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

Opportunities Assessment for Diabetes Therapeutics - Australia

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2008³â 12¿ù »óǰÄÚµå 79387
ÆäÀÌÁö Á¤º¸ 53 Pages
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Australia.

Table of Contents

1. EXECUTIVE SUMMARY

Overview

  • Executive Summary

2. DIABETES MARKET

Market Overview

  • Introduction
  • Context for Study
  • Report Scope and Segmentation
  • Methodology
  • Restraints in Forecasts

3. AUSTRALIAN DIABETES MARKET

Market Overview

  • Introduction
  • Market Engineering Measurements
  • Government Initiatives
  • PBS Drug Listing Process

Market Forecasts and Trends

  • Patient Forecasts
  • Cost of Treatment

Treatment and Diagnosis

  • Key Treaters and Patient Flow
  • Diagnostic Tests and Monitoring
  • Treatment Options
  • Product Launches
  • Clinical Trials

Competitive Analysis

  • Competitive Structure
  • Market Share Analysis
  • Future Trends
  • Challenges Faced by Physicians

4. APPENDIX

Australia

  • Australia
Back to Top